Ping Chen , Hao-Min Li , Chu-Yu Huang , Jie-Jing Liu , Lin-Yi Luo , Jing Luo , Xing-Jun Huo , Mei Huang , Ying-Lin Yin , Lei Mou , Yong-Chang Ouyang
{"title":"A universal single-plasmid, single-promoter system for efficient protein display and RNA encapsulation in MS2 virus-like particles","authors":"Ping Chen , Hao-Min Li , Chu-Yu Huang , Jie-Jing Liu , Lin-Yi Luo , Jing Luo , Xing-Jun Huo , Mei Huang , Ying-Lin Yin , Lei Mou , Yong-Chang Ouyang","doi":"10.1016/j.jbiotec.2025.09.004","DOIUrl":null,"url":null,"abstract":"<div><div>Bacteriophage MS2 virus-like particles (VLPs) represent a promising platform for biomedical applications. However, challenges remain in integrating protein display, RNA encapsulation, and convenient purification methods. Here, we developed a universal single-plasmid single-promoter system (USS) that enables modular assembly of multifunctional VLPs through designated <em>Pst</em>I (protein insertion) and <em>Kpn</em>I (RNA encapsulation) sites. The USS system achieved: 1) Efficient display of large protein molecules (e.g., EGFP, Nanobody N16) on each VLP surface while encapsulating target RNA; 2) Rapid one-step purification via His-tag affinity chromatography, bypassing ultracentrifugation; 3) The resulting VLPs exhibit thermal stability (60°C for 15 min) and nuclease resistance. Functional validation demonstrated: 1) Diagnostics: <em>CoviN</em>-encapsulated VLPs served as RT-qPCR controls for COVID-19 detection (linear range: 10<sup>2</sup>–10<sup>8</sup> copies/μL); 2) Dual functionality for co-delivery: N16-VLPs with <em>shPCSK9</em> suppressed protein PCSK9 expression by 68 % (<em>p</em> < 0.01) in Hepa1–6 cells and bound PD-L1 with nanomolar affinity (EC50 = 1.6 μg/mL). Crucially, the simplicity of USS eliminated the need for multi-plasmid constructs, providing a streamlined approach to VLPs production that is both efficient and scalable for applications from molecular diagnostics to combination therapies.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"408 ","pages":"Pages 132-141"},"PeriodicalIF":3.9000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168165625002317","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Bacteriophage MS2 virus-like particles (VLPs) represent a promising platform for biomedical applications. However, challenges remain in integrating protein display, RNA encapsulation, and convenient purification methods. Here, we developed a universal single-plasmid single-promoter system (USS) that enables modular assembly of multifunctional VLPs through designated PstI (protein insertion) and KpnI (RNA encapsulation) sites. The USS system achieved: 1) Efficient display of large protein molecules (e.g., EGFP, Nanobody N16) on each VLP surface while encapsulating target RNA; 2) Rapid one-step purification via His-tag affinity chromatography, bypassing ultracentrifugation; 3) The resulting VLPs exhibit thermal stability (60°C for 15 min) and nuclease resistance. Functional validation demonstrated: 1) Diagnostics: CoviN-encapsulated VLPs served as RT-qPCR controls for COVID-19 detection (linear range: 102–108 copies/μL); 2) Dual functionality for co-delivery: N16-VLPs with shPCSK9 suppressed protein PCSK9 expression by 68 % (p < 0.01) in Hepa1–6 cells and bound PD-L1 with nanomolar affinity (EC50 = 1.6 μg/mL). Crucially, the simplicity of USS eliminated the need for multi-plasmid constructs, providing a streamlined approach to VLPs production that is both efficient and scalable for applications from molecular diagnostics to combination therapies.
期刊介绍:
The Journal of Biotechnology has an open access mirror journal, the Journal of Biotechnology: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
The Journal provides a medium for the rapid publication of both full-length articles and short communications on novel and innovative aspects of biotechnology. The Journal will accept papers ranging from genetic or molecular biological positions to those covering biochemical, chemical or bioprocess engineering aspects as well as computer application of new software concepts, provided that in each case the material is directly relevant to biotechnological systems. Papers presenting information of a multidisciplinary nature that would not be suitable for publication in a journal devoted to a single discipline, are particularly welcome.